Eberhard Schulz

12.3k citations
120 papers · 9.4k · 1 hit paper · h-index 46

Impact in

Papers in

Eberhard Schulz

118 papers receiving 9.2k citations

Eberhard Schulz's Hit Papers

Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction 2011 · 441 citations
4410+5+10Years since publication100200300400

Peers

Eberhard Schulz
Comparison fields: 5 of 128
  • Physiology 3.8k
  • Cardiology and Cardiovascular Medicine 2k
  • Biochemistry 424
  • Endocrinology, Diabetes and Metabolism 775
  • Speech and Hearing 141
Replace Philip Wenzel with:
Philip Wenzel Germany
Matthias Walter Oelze Germany
Louise A. McCann United States
Swenja Kröller‐Schön Germany
Thomas A. Heitzer Germany
Shintaro Kinugawa Japan
Ascan Warnholtz Germany
Masato Eto Japan
Sumito Ogawa Japan
Kazuhisa Maeda Japan
Eberhard Schulz relative to Philip Wenzel Germany Philip Wenzel's profile →
Citations per field
00.5×1.7×
Philip Wenzel · 1×
Citations per year

Countries citing papers authored by Eberhard Schulz

Since Specialization
Citations

This map shows the geographic impact of Eberhard Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Schulz more than expected).

Fields of papers citing papers by Eberhard Schulz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eberhard Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Schulz. The network helps show where Eberhard Schulz may publish in the future.

Co-authors

The 25 scholars most cited alongside Eberhard Schulz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eberhard Schulz Line = papers co-authored together Eberhard Schulz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1999596
2 2002582
3
Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
Hit paper breakdown →
2011441
4 2011427
5 2007376
6 2008364
7 2008322
8 2014268
9 2004267
10 2017259
11 2015239
12 2012227
13 2013227
14 2015208
15 2008190
16 2008186
17 2006185
18 2012162
19 2002141
20 2003140

About Eberhard Schulz

Eberhard Schulz is a scholar working on Physiology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery and Immunology, having authored 120 papers that have together received 9.4k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (66 papers), Cardiac Valve Diseases and Treatments (26 papers), Coronary Interventions and Diagnostics (9 papers), Diabetes Treatment and Management (6 papers), Mitochondrial Function and Pathology (5 papers), Renin-Angiotensin System Studies (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Physiology (3.8k citations), Cardiology and Cardiovascular Medicine (2k citations), Biochemistry (424 citations), Endocrinology, Diabetes and Metabolism (775 citations) and Speech and Hearing (141 citations). Eberhard Schulz has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Thomas Münzel, Andreas Daiber, Philip Wenzel, Matthias Walter Oelze, Tommaso Gori, John F. Keaney, Swenja Kröller‐Schön, Thomas Jansen, Sebastian Steven and Ascan Warnholtz. Their work appears in journals such as European Heart Journal, Arteriosclerosis Thrombosis and Vascular Biology, Circulation, Basic Research in Cardiology and Antioxidants and Redox Signaling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact